Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

AP-III-a4

(Synonyms: ENOblock) Copy Product Info
🥰Excellent

Synonyms: ENOblock

Catalog No. T6759 Copy Product Info
Purity: 99.90%
🥰Excellent
AP-III-a4 (ENOblock) is the first non-substrate analogue that directly binds to enolase to inhibit its catalytic activity with an IC50 of 0.576 μM, thereby blocking cancer cell metastasis in vivo. AP-III-a4 can be used in research on tumor metabolism, metastasis, and diseases related to carbohydrate metabolism.
AP-III-a4
Cas No. 1177827-73-4
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$47In StockIn Stock
2 mg$71In StockIn Stock
5 mg$123In StockIn Stock
10 mg$198In StockIn Stock
25 mg$388In StockIn Stock
50 mg$619In StockIn Stock
100 mg$987In StockIn Stock
200 mg$1,450-In Stock
1 mL x 10 mM (in DMSO)$159In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.90%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
AP-III-a4 (ENOblock) is the first non-substrate analogue that directly binds to enolase to inhibit its catalytic activity with an IC50 of 0.576 μM, thereby blocking cancer cell metastasis in vivo. AP-III-a4 can be used in research on tumor metabolism, metastasis, and diseases related to carbohydrate metabolism.
Targets & IC50
Enolase:0.576 μM
In vitro
Methods: H446 cells were treated with AP-III-a4 (1 μM) for 24 hours, followed by detection of ENO1 enzyme activity using the ENO1 Human Activity Assay Kit.
Results: AP-III-a4 treatment inhibited ENO1 activity. [1]
In vivo
Methods: UM-1 cells (1×10⁶) were subcutaneously implanted into nude mice. Once tumor volume reached 100 mm³, AP-III-a4 was administered via intraperitoneal injection at a dose of 20 mg/kg body weight, every other day for 28 days.
Results: Tumor volume and weight in AP-III-a4-treated mice were significantly smaller than in the control group. [2]
SynonymsENOblock
Kinase Assay
Enolase activity assay is in the 2.0 mM MgSO4 and 400 mM KCl in the absence or presence of ENOblock or NaF, at 37°C by incubating pure enolase (3–9 U) in a buffer containing 50 mM imidazole-HCl (pH 6.8). The reaction is initiated by adding 1 μmol of 2-phospho-D-glycerate, and the OD is measured after 10 min of reaction time with a spectrophometer at 240 nm.
Cell Research
HCT116 cells(3 x 10E5) are seeded in a 6 well plate. 24 h later, cells are treated with AP-III-a4 (5 μM) for 24hours.
Animal Research
In HCT116-xenotransplanted zebrafish tumor xenograft model, were treated with AP-III-a4 of 10 μM.
Chemical Properties
Molecular Weight594.72
FormulaC31H43FN8O3
Cas No.1177827-73-4
SmilesNCCOCCOCCNC(=O)Cc1ccc(Nc2nc(NCC3CCCCC3)nc(NCc3ccc(F)cc3)n2)cc1
Relative Density.1.250 g/cm3 (Predicted)
Storage & Solubility Information
StorageStore at low temperature Pure form: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 257.5 mg/mL (432.98 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (8.41 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.6815 mL8.4073 mL16.8146 mL84.0732 mL
5 mM0.3363 mL1.6815 mL3.3629 mL16.8146 mL
10 mM0.1681 mL0.8407 mL1.6815 mL8.4073 mL
20 mM0.0841 mL0.4204 mL0.8407 mL4.2037 mL
50 mM0.0336 mL0.1681 mL0.3363 mL1.6815 mL
100 mM0.0168 mL0.0841 mL0.1681 mL0.8407 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Keywords

Related Tags: AP-III-a4 chemical structure | AP-III-a4 in vivo | AP-III-a4 in vitro | AP-III-a4 formula | AP-III-a4 molecular weight